University of Wollongong
Browse

Activity of a novel protonophore against methicillin-resistant Staphylococcus aureus

Download (513.12 kB)
journal contribution
posted on 2024-11-14, 23:34 authored by Nagendran Tharmalingam, Elamparithi Jayamani, Rajmohan Rajamuthiah, Dawilmer Castillo, Beth Fuchs, Michael KelsoMichael Kelso, Eleftherios Mylonakis
Aim: Compound 1-(4-chlorophenyl)-4,4,4-trifluoro-3-hydroxy-2-buten-1-one (compound 1) was identified as a hit against methicillin-resistant Staphylococcus aureus (MRSA) strain MW2. Methods & results: The MIC of compound 1 against MRSA was 4 μg/ml. The compound showed enhanced activity at acidic pH by lowering bacterial intracellular pH and exhibited no lysis of human red blood cells at up to 64 μg/ml and its IC50 against HepG2 cells was 32 μg/ml. The compound reduced 1-log10 colony forming units of intracellular MRSA in macrophages and prolonged the survival of MRSA-infected Caenorhabditis elegans (p = 0.0015) and Galleria mellonella (p = 0.0002). Conclusion: Compound 1 is a protonophore with potent in vitro and in vivo activity against MRSA and no toxicity in mammalian cells up to 8 μg/ml that warrants further investigation as a novel antibacterial.

History

Citation

Tharmalingam, N., Jayamani, E., Rajamuthiah, R., Castillo, D., Fuchs, B. Burgwyn., Kelso, M. J. & Mylonakis, E. (2017). Activity of a novel protonophore against methicillin-resistant Staphylococcus aureus. Future Medicinal Chemistry, 9 (12), 1401-1411.

Journal title

Future Medicinal Chemistry

Volume

9

Issue

12

Pagination

1401-1411

Language

English

RIS ID

115987

Usage metrics

    Categories

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC